Hedge Fund - OrbiMed Advisors
Regeneron Pharmaceuticals Inc. (REGN)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2024 - Q4 (2024-12-31) | $0 | 0% | 0 | $839.22 |
| 2 | 2024 - Q3 (2024-09-30) | $47,516,048 | 0.86% | 45,200 | $1112.86 |
| 3 | 2024 - Q2 (2024-06-30) | $23,963,484 | 0.47% | 22,800 | $969.40 |
| 4 | 2024 - Q1 (2024-03-31) | $21,944,772 | 0.4% | 22,800 | $950.88 |
| 5 | 2023 - Q4 (2023-12-31) | $11,856,915 | 0.23% | 13,500 | $823.50 |
| 6 | 2023 - Q3 (2023-09-30) | $11,109,960 | 0.23% | 13,500 | $785.91 |
| 7 | 2023 - Q2 (2023-06-30) | $9,700,290 | 0.17% | 13,500 | $771.00 |
| 8 | 2023 - Q1 (2023-03-31) | $19,720,080 | 0.38% | 24,000 | $754.21 |
| 9 | 2022 - Q3 (2022-09-30) | $0 | 0% | 0 | $629.39 |
| 10 | 2022 - Q2 (2022-06-30) | $13,123,000 | 0.23% | 22,200 | $650.01 |
| 11 | 2021 - Q4 (2021-12-31) | $0 | 0% | 0 | $614.83 |
| 12 | 2021 - Q3 (2021-09-30) | $8,206,000 | 0.09% | 13,560 | $620.82 |
| 13 | 2020 - Q3 (2020-09-30) | $0 | 0% | 0 | $606.33 |
| 14 | 2020 - Q2 (2020-06-30) | $19,271,000 | 0.27% | 30,900 | $567.62 |
| 15 | 2020 - Q1 (2020-03-31) | $8,399,000 | 0.14% | 17,200 | $412.49 |
| 16 | 2019 - Q4 (2019-12-31) | $78,588,000 | 1.12% | 209,300 | $336.44 |
| 17 | 2019 - Q3 (2019-09-30) | $63,275,000 | 1.2% | 228,100 | $295.91 |
| 18 | 2019 - Q2 (2019-06-30) | $67,545,000 | 1.04% | 215,800 | $332.92 |
| 19 | 2019 - Q1 (2019-03-31) | $88,201,000 | 1.36% | 214,800 | $411.79 |
| 20 | 2018 - Q4 (2018-12-31) | $82,954,000 | 1.53% | 222,100 | $366.02 |
| 21 | 2018 - Q3 (2018-09-30) | $159,353,000 | 1.91% | 394,400 | $380.58 |
| 22 | 2018 - Q2 (2018-06-30) | $128,509,000 | 1.53% | 372,500 | $312.75 |
| 23 | 2018 - Q1 (2018-03-31) | $331,584,000 | 4.11% | 962,900 | $347.81 |
| 24 | 2017 - Q4 (2017-12-31) | $321,295,000 | 4.06% | 854,600 | $405.00 |
| 25 | 2017 - Q3 (2017-09-30) | $256,097,000 | 2.44% | 572,770 | $475.84 |
| 26 | 2017 - Q2 (2017-06-30) | $229,249,000 | 2.4% | 466,770 | $437.61 |
| 27 | 2017 - Q1 (2017-03-31) | $146,545,000 | 1.66% | 378,170 | $370.66 |
| 28 | 2016 - Q4 (2016-12-31) | $130,427,000 | 1.66% | 355,300 | $380.27 |
| 29 | 2016 - Q3 (2016-09-30) | $142,838,000 | 1.62% | 355,300 | $401.14 |
| 30 | 2016 - Q2 (2016-06-30) | $178,072,000 | 1.85% | 509,900 | $385.12 |
| 31 | 2016 - Q1 (2016-03-31) | $192,115,000 | 2.02% | 533,000 | $412.07 |
| 32 | 2015 - Q4 (2015-12-31) | $262,206,000 | 2.37% | 483,000 | $541.81 |
| 33 | 2015 - Q3 (2015-09-30) | $226,849,000 | 2.29% | 487,700 | $537.03 |
| 34 | 2015 - Q2 (2015-06-30) | $235,578,000 | 1.96% | 461,800 | $488.62 |
| 35 | 2015 - Q1 (2015-03-31) | $190,434,000 | 1.62% | 421,800 | $423.80 |
| 36 | 2014 - Q4 (2014-12-31) | $160,080,000 | 1.52% | 390,200 | $393.26 |
| 37 | 2014 - Q3 (2014-09-30) | $133,248,000 | 1.39% | 369,600 | $335.16 |
| 38 | 2014 - Q2 (2014-06-30) | $92,255,000 | 1.08% | 326,600 | $296.38 |
| 39 | 2014 - Q1 (2014-03-31) | $161,851,000 | 1.99% | 539,000 | $308.09 |
| 40 | 2013 - Q4 (2013-12-31) | $203,347,000 | 2.98% | 738,800 | $287.62 |
| 41 | 2013 - Q3 (2013-09-30) | $160,534,000 | 2.86% | 513,100 | $263.04 |
| 42 | 2013 - Q2 (2013-06-30) | $78,955,000 | 1.67% | 351,100 | $232.86 |
| 43 | 2013 - Q1 (2013-03-31) | $42,654,000 | 0.99% | 241,800 | $171.67 |
| 44 | 2012 - Q4 (2012-12-31) | $37,601,000 | 1.15% | 219,800 | $163.50 |
| 45 | 2012 - Q3 (2012-09-30) | $33,020,000 | 0.94% | 216,300 | $136.74 |
| 46 | 2012 - Q1 (2012-03-31) | $37,237,000 | 1.1% | 319,300 | $97.71 |
| 47 | 2011 - Q4 (2011-12-31) | $30,919,000 | 1.01% | 557,800 | $56.50 |
| 48 | 2011 - Q3 (2011-09-30) | $2,479,000 | 0.09% | 42,600 | $58.22 |
| 49 | 2011 - Q2 (2011-06-30) | $4,367,000 | 0.08% | 77,000 | $52.78 |
| 50 | 2011 - Q1 (2011-03-31) | $3,460,000 | 0.11% | 77,000 | $36.59 |
The displayed share prices are average quarterly stock market prices.